SN Oncology Webinar Series

SN Oncology Webinar Series

Springer Nature

Research Seminars by Springer Nature

These webinars bring together international experts to discuss ongoing developments on hot topics in cancer research.

Speakers
Community
Prof. Haidong Dong
Prof. Adrian Harris
Prof. Jan Paul Medema
Prof. Yi-Long Wu
Dr. Alexia-Ileana Zaromytidou
Prof. Klaus Pantel
Prof. Dennis Lo
Dr. Myron G. Best
+79
Dr Ben Kaube
Prof. Dr. Torsten Tonn MD, PHD
Prof. Jianhua Yu
Professor Subramaniam Malarkannan Ph.D.
Dr. Andrew Preston
Prof. Peter Vincent
Dr. Marziyeh Nazari
Dr Paraskevi Mallini
+1278
Research Seminars by Springer Nature
Research Seminars by Springer Nature
Springer Nature Cancer Community

Seminars in preparation

Browse by year
Clinical Experience of Using Integrated Whole Genome and Transcriptome Sequencing as A Framework for Pediatric and Adolescent Acute Myeloid Leukemia Diagnosis and Risk Assessment
In preparation
St. Jude Children's Research Hospital

Clinical Experience of Using Integrated Whole Genome and Transcriptome Sequencing as A Framework for Pediatric and Adolescent Acute Myeloid Leukemia Diagnosis and Risk Assessment

Rebecca Voss, St. Jude Children's Research Hospital
Plot twist: homologous recombination actually promotes the development of cancer!
Oct 8
Centre National de la Recherche Scientifique
Université Paris Cité

Plot twist: homologous recombination actually promotes the development of cancer!

Dr Lopez, Institut Cochin, Paris, France
RSVP to seminar
Selection of Donors for Hematopoietic Cell Transplantation: Donor age is becoming more and more important
In preparation
TU Dresden
DKMS Foundation

Selection of Donors for Hematopoietic Cell Transplantation: Donor age is becoming more and more important

Professor, DKMS Group

Published seminars

Browse by year
Specific T Cell Immune Responses Against Leukemic Cells, as well as Leukemic Progenitor Cells, in Acute Myeloid Leukemia
Oct 1
Hull York Medical School

Specific T Cell Immune Responses Against Leukemic Cells, as well as Leukemic Progenitor Cells, in Acute Myeloid Leukemia

Barbara Guinn, Hull York Medical School
The antibiotic paradox in allogeneic stem cell transplantation
Sep 18
University of Regensburg

The antibiotic paradox in allogeneic stem cell transplantation

Ernst Holler, University of Regensburg
Outcomes of Patients Treated With Venetoclax Plus Azacitidine Versus Azacitidine Alone Stratified by Advanced Age and Acute Myeloid Leukemia Composite Model
Sep 3
University of Rome Tor Vergata

Outcomes of Patients Treated With Venetoclax Plus Azacitidine Versus Azacitidine Alone Stratified by Advanced Age and Acute Myeloid Leukemia Composite Model

Adriano Venditti, University of Rome Tor Vergata
agenT-797: Allogeneic iNKT Cell Therapy for the Treatment of Cancer - Complete Clinical Response in a R/R Germ Cell Tumor
Aug 22
Sarah Cannon Research Institute

agenT-797: Allogeneic iNKT Cell Therapy for the Treatment of Cancer - Complete Clinical Response in a R/R Germ Cell Tumor

Benjamin Garmezy, Sarah Cannon Research Institute
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL
Jun 30
German Cancer Research Center
University Hospital Ulm

NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL

Alena Ehrmann, German Cancer Research Center and University Hospital Ulm
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants
May 28
Northwestern University

Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

Dr Godley, Northwestern University
Anti-T lymphocyte Globulin plus Posttransplant Cyclophosphamide 25 mg/kg versus Posttransplant Cyclophosphamide 50 mg/kg in Patients with Acute Leukemias
Apr 18

Anti-T lymphocyte Globulin plus Posttransplant Cyclophosphamide 25 mg/kg versus Posttransplant Cyclophosphamide 50 mg/kg in Patients with Acute Leukemias

Turgay Ulas, Ankara Oncology Hospital
Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis
Apr 8
Cardiff University

Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis

Andrew R. Tee, Cardiff University
Early Morbimortality in Autologous Hematopoietic Cell Transplantation Performed on Outpatient Basis in Patients with Autoimmune Diseases: Experience in 1700 Patients
Mar 19
Clínica Ruiz

Early Morbimortality in Autologous Hematopoietic Cell Transplantation Performed on Outpatient Basis in Patients with Autoimmune Diseases: Experience in 1700 Patients

Professor Guillermo J.- Ruiz-Argüelles, Clínica Ruiz